The Biotechnology and Pharmaceutical Science team at CytomX Therapeutics is integral to the advancement of cancer treatment through its innovative Probody® therapeutic platform. This team specializes in research and development, focusing on oncology and immuno-oncology, protein sciences, bioinformatics, and bioanalysis, ensuring the successful progression of drug candidates from early-stage development to clinical supply chain readiness. Their collaborative efforts drive the scientific and operational excellence necessary for translating groundbreaking therapies into effective clinical applications.